Editas Medicine Announces Second Quarter 2018 Results and Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall St futures steady with focus on Mideast talks, US-China summit
- Activist Jana Partners calls for Six Flags sale - WSJ
- Oil holds near two-week lows while diesel cracks hit record peak
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
Editas Medicine (EDIT) Misses Q2 EPS by 15c
August 6, 2018 4:36 PM EDTEditas Medicine (NASDAQ: EDIT) reported Q2 EPS of ($0.82), $0.15 worse than the analyst estimate of ($0.67). Revenue for the quarter came in at $7.4 million versus the consensus estimate of $6.73 million.
For earnings history and earnings-related data on Editas Medicine (EDIT) click here.
... More